NASDAQ · Drug Manufacturers - Specialty & Generic

Sunshine Biopharma Inc. (SBFM) Stock

$0.43 -38.57% NASDAQ: SBFM Healthcare

Valuation

MetricValue
Price$0.43
Market Cap$1.02M
P/E Ratio-0.04
P/B Ratio0.02
P/S Ratio0.03
EPS (TTM)$-14.40
52-Week High$24.30
52-Week Low$0.37
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-24.23%
ROA-17.34%
ROCE-18.56%
Gross Margin32.49%
Operating Margin-12.90%
Net Margin-16.50%
Debt/Equity0.02
Current Ratio4.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$4.0M$24.0M$35.0M$36.0M
Operating Profit$-2.0M$-9.0M$-5.0M$-6.0M$-4.0M
Net Profit$-12.0M$-27.0M$-5.0M$-5.0M$-6.0M
EPS$-95200.00$-35236.40$-3513.60$-73.20$-14.40
Op Margin-1068.2%-199.6%-19.9%-16.7%-12.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0M$30.0M$27.0M$31.0M$30.0M
Total Liabilities$2.0M$8.0M$6.0M$7.0M$7.0M
Cash$2.0M$22.0M$16.0M$10.0M$9.0M
Borrowings$2.0M$1.0M$1.0M$1.0M$1.0M

Latest News

Sunshine Biopharma and University of Arizona Publish Significant New Research Findings ACCESS Newswire · Jul 20, 2026 Sunshine Biopharma Secures Approval for Generic Anastrozole in Canada MT Newswires · Jun 25, 2026 Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R) ACCESS Newswire · Jun 25, 2026 Sunshine Biopharma Says Rivaroxaban Received Canadian Approval MT Newswires · Jun 1, 2026 Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R) ACCESS Newswire · Jun 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-5.0M$-9.0M$-13.0M$-5.0M
Investing Cash Flow$0$-15.0M$-1.0M$-5.0M$-1.0M
Financing Cash Flow$0$-2.0M$-1.0M$-3.0M$0
Net Cash Flow$1.0M$20.0M$-6.0M$-7.0M$-1.0M
Free Cash Flow$-2.0M$-6.0M$-10.0M$-15.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA2.29
FCF Yield-449.37%
Quick Ratio3.30
Interest Coverage0.00
Return 1Y-87.67%
Return 3Y-99.98%
Return 5Y—

Ownership

Insiders Held0.43%
Institutions Held11.44%
Institutions Float Held11.49%
Institutional HolderSharesReport Date
Citadel Advisors Llc4,6252026-03-31
Two Sigma Securities, LLC2,3482026-03-31
Xtx Topco Ltd2,1462026-03-31
Morgan Stanley1,4632026-03-31
Commonwealth Equity Services, LLC1,3442026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACXPAcurx Pharmaceuticals, Inc. $1.25 -3.85% -0.36 $5.37M 0.00%
BFRIBiofrontera Inc. $0.92 -1.77% -1.69 $11.76M 0.00%
CHEKCheck-Cap Ltd. $1.86 +1.64% -0.43 $10.88M 0.00%
EVOKEvoke Pharma, Inc. $11.00 +0.00% -6.96 $18.95M 0.00%
HCWBHCW Biologics Inc. $1.53 -1.92% -0.03 $531891 0.00%

About Sunshine Biopharma Inc.

Sunshine Biopharma Inc. is led by CEO Steve N. Slilaty, employs 52 people, headquartered in CA, publicly traded since 2022.

Sunshine Biopharma Inc. (SBFM) stock trades at $0.43 with a market capitalization of $1.02M. The stock is valued at a price-to-earnings (P/E) ratio of -0.04, price-to-book of 0.02, price-to-sales of 0.03. Over the past 52 weeks the stock has ranged between $0.37 and $24.30, and currently trades 98.2% below its 52-week high.

On profitability, Sunshine Biopharma Inc. generates a return on equity (ROE) of -24.23%, return on capital employed of -18.56%, an operating margin of -12.90%, a net profit margin of -16.50%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1167.49 -0.18% JNJ Johnson & Johnson $258.43 +0.76% ABBV AbbVie Inc. $274.80 +0.87% MRK Merck & Company, Inc. Common Stock (new) $144.19 +1.27% UNH UnitedHealth Group Incorporated Common Stock (DE) $383.12 +3.28% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $656.23 +0.65% AMGN Amgen Inc. $410.26 +0.69% GILD Gilead Sciences, Inc. $149.11 +1.37% ABT Abbott Laboratories $100.17 +1.71% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides